Synthimed Labs Private Limited
Dr. Narender Rao Somisetti is an accomplished professional in the pharmaceutical and chemical industries, currently serving as the Chief Scientific Officer at Synthimed Labs Private Limited since January 2025. With extensive experience in research and development, Dr. Somisetti previously held the position of Vice President-R&D at Metrochem API Private Limited and General Manager, Head-API Process Development at Lupin Limited. Dr. Somisetti's career includes roles at various organizations, focusing on process development of APIs and contract research. Academic credentials include a Ph.D. in Organic Chemistry, an MSc in Organic Chemistry from Andhra University, and a PG Diploma in Regulatory Affairs.
This person is not in the org chart
This person is not in any teams
Synthimed Labs Private Limited
In March 2024, Synthimed took over the esteemed legacy established by Ind-Swift Laboratories since 1995. Our primary focus is on nurturing a strong domestic presence while strategically expanding into established regulated markets and emerging economies. Each step forward stands as a testament to the dedication of our united team, whose unwavering commitment drives us toward new heights of achievement. Equipped with cutting-edge manufacturing facilities, an independent R&D Centre, and a proven track record of regulatory approvals, Synthimed is dedicated to becoming a reliable partner in the global pharmaceutical arena. Our strengths lie in our capabilities for API development, production of finished dosage forms, non-infringing processes, and world-class facilities for contract manufacturing. As we move forward, Synthimed remains steadfast in upholding the highest standards of quality and innovation, ensuring our ongoing contribution to the advancement of healthcare worldwide.